Titan Biotech Limited share price
BSE: TITANBIO
Key numbers
- Market cap
- ₹ 1,647 Cr
- Current price
- ₹ 398.70
- 52-week high / low
- ₹ 556 / 171
- Stock P/E
- 257.2
- Book value
- ₹ 43.9
- Dividend yield
- 0.13%
- ROCE
- 22.7%
- ROE
- 17.8%
- Debt to equity
- 0.03
- Sales growth (3 yrs)
- 12.7%
- Profit growth (3 yrs)
- 6.4%
- 1-year return
- 103.3%
About Titan Biotech Limited
Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen and protein products, such as wheat hydrolysate protein, corn hydrolysate protein, bovine collagen peptide, collagen peptide, fish collage, undernatured chicken collagen type II, mucopolysaccharides, chicken protein isolate, soya protein isolate, and pea protein isolate; and brown rice protein, milk protein, protein hydrolysate, bovine cartilage extract, L-glutathione, cow colostrum powder, collagen peptides, whey protein, sodium caseinate, chondroitin sulphate, and hyaluronic acid. The company also provides coenzyme Q10, glucosamine KCL/HCL, methyl sulfonyl methane, chelated minerals, and peptone; OX bile extract, cholic acid, cerebroprotein hydrolysate, and iron protein succinylate; medicinal yeast and brewer yeast protein; and animal nutrition comprising mannan oligosaccharide, amino chelated mineral, sodium and calcium butyrate, sodium and calcium propionate, protein hydrolysate, and active dry yeast. In…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 47 | 54 | 57 | 49 | 59 |
| Operating profit | 9 | 9 | 11 | 10 | 12 |
| Net profit | 7 | 8 | 9 | 7 | 11 |
| EPS (₹) | 8.30 | 1.88 | 2.06 | 1.63 | 2.63 |
Peers in Biotechnology
Data for information only, not investment advice. Prices end of day.